Alan Turing Institute, Kings Cross, London, UK.
Departments of Mathematics and Statistics, University of Warwick, Coventry, UK.
BMJ. 2020 Mar 20;368:l6927. doi: 10.1136/bmj.l6927.
Machine learning, artificial intelligence, and other modern statistical methods are providing new opportunities to operationalise previously untapped and rapidly growing sources of data for patient benefit. Despite much promising research currently being undertaken, particularly in imaging, the literature as a whole lacks transparency, clear reporting to facilitate replicability, exploration for potential ethical concerns, and clear demonstrations of effectiveness. Among the many reasons why these problems exist, one of the most important (for which we provide a preliminary solution here) is the current lack of best practice guidance specific to machine learning and artificial intelligence. However, we believe that interdisciplinary groups pursuing research and impact projects involving machine learning and artificial intelligence for health would benefit from explicitly addressing a series of questions concerning transparency, reproducibility, ethics, and effectiveness (TREE). The 20 critical questions proposed here provide a framework for research groups to inform the design, conduct, and reporting; for editors and peer reviewers to evaluate contributions to the literature; and for patients, clinicians and policy makers to critically appraise where new findings may deliver patient benefit.
机器学习、人工智能和其他现代统计方法为挖掘和利用以前未被开发的、快速增长的患者数据资源提供了新的机会。尽管目前正在进行大量有前景的研究,特别是在影像学方面,但整个文献缺乏透明度、明确的报告以促进可重复性、对潜在伦理问题的探索,以及对有效性的明确展示。存在这些问题的原因有很多,其中最重要的原因之一(我们在这里提供了一个初步的解决方案)是目前缺乏针对机器学习和人工智能的最佳实践指导。然而,我们认为,从事涉及机器学习和人工智能的健康研究和影响项目的跨学科团队,如果能够明确解决透明度、可重复性、伦理和有效性方面的一系列问题(TREE),将会受益。这里提出的 20 个关键问题为研究团队提供了一个框架,用于告知设计、进行和报告;供编辑和同行评审者评估对文献的贡献;并让患者、临床医生和政策制定者批判性地评估新发现可能为患者带来的益处。